Symbols

CRL

Charles River Laboratories International·NYSE

--(--)

CRL fundamentals

CRL Q4 2025 Earnings

Charles River Laboratories International (CRL) released its earnings on Feb 18, 2026: revenue was 994.23M (YoY -0.83%), beat estimates; EPS was 2.39 (YoY -10.15%), beat estimates.

Revenue / YoY

994.23M

-0.83%

EPS / YoY

2.39

-10.15%

Report date

Feb 18, 2026

CRL Earnings Call Summary for Q4,2025

Revenue and Margin: 2026 guidance for flat to -1% organic revenue growth, with non-GAAP EPS $10.70-$11.20 (+4%-9% YoY). Operating margin to expand 20-50 bps YoY.
Strategic Acquisitions: K.F. (Cambodia) to reduce NHP costs, PathoQuest to enhance biologics testing. Divestitures expected to complete by mid-2026.
Demand Trends: DSA net book-to-bill 1.12x in Q4, with cautious optimism for H2 2026 growth. Biotech funding rebounded to $28B in Q4.
Q1 Challenges: Mid-teens operating margin due to NHP timing, stock comp costs, and higher DSA sourcing expenses.
AI and NAMs: Long-term focus on NAMs as incremental tools, with Retrogenix and virtual control groups driving efficiency.
Leadership Transition: Birgit Girshick to succeed Jim Foster as CEO, with seamless transition planned.

Earnings

EPS

Revenue

Revenue & Expenses

CRL has released its 2025 Q4 earnings report, with revenue of 994.23M, reflecting a YoY change of -0.83%, and net profit of -276.29M, showing a YoY change of -29.26%. The Sankey diagram below clearly presents CRL's revenue sources and cost distribution.

Key Indicators

Charles River Laboratories International (CRL) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Charles River Laboratories International (CRL)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Charles River Laboratories International (CRL)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Charles River Laboratories International (CRL)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown